日本消化器病学会アーカイブシステム

セッション	検索結果は4件です。 Management of low dose aspirin and clopidogrel in clinical practice - A GI perspective Lanas　Angel（University of Zaragoza, Spain） Low dose aspirin（ASA）therapy has been associated with a wide spectrum of lesions and adverse events in the upper GI tract, which may lead to poor adherence or discontinuation of the antiplatelet thera... 第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI Event timing GI damages and eradication of H.pylori eradication in LDA user Kawai　Takashi（Endoscopy Center, Tokyo Medical University Hospital, Japan） Background：Low-dose aspirin（LDA）is widely used for the prevention of cardiovascular events. But LDA has several adverse gastrointestinal（GI）effects, including GI bleeding. MAGIC（Management of Aspirin-... 第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI Proton pump inhibitors and antiplatelet agents：Safe to prescribe together? Abraham　Neena S.（Department of Medicine, Division of Gastroenterology, Mayo Clinic College of Medicine, USA） Dual antiplatelet therapy（aspirin+thienopyridine）is recommended for the treatment of acute coronary syndrome and to prevent stent thrombosis following coronary intervention with stent insertion, but i... 第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI Role of CYP2C19 in antiplatelet therapy and PPIs Furuta　Takahisa（Center for Clinical Research, Hamamatsu University, Japan）　Anti-platelet therapy is now widely performed in cardiovascular disorders. Aspirin and clopidogrel are the most important cornerstone agents in this therapy. Aspirin sometimes induces gastric mucosal... 第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI

セッション

検索結果は4件です。

Management of low dose aspirin and clopidogrel in clinical practice - A GI perspective: Lanas　Angel（University of Zaragoza, Spain）
Low dose aspirin（ASA）therapy has been associated with a wide spectrum of lesions and adverse events in the upper GI tract, which may lead to poor adherence or discontinuation of the antiplatelet thera...
第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI
Event timing GI damages and eradication of H.pylori eradication in LDA user: Kawai　Takashi（Endoscopy Center, Tokyo Medical University Hospital, Japan）
Background：Low-dose aspirin（LDA）is widely used for the prevention of cardiovascular events. But LDA has several adverse gastrointestinal（GI）effects, including GI bleeding. MAGIC（Management of Aspirin-...
第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI
Proton pump inhibitors and antiplatelet agents：Safe to prescribe together?: Abraham　Neena S.（Department of Medicine, Division of Gastroenterology, Mayo Clinic College of Medicine, USA）
Dual antiplatelet therapy（aspirin+thienopyridine）is recommended for the treatment of acute coronary syndrome and to prevent stent thrombosis following coronary intervention with stent insertion, but i...
第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI
Role of CYP2C19 in antiplatelet therapy and PPIs: Furuta　Takahisa（Center for Clinical Research, Hamamatsu University, Japan）
　Anti-platelet therapy is now widely performed in cardiovascular disorders. Aspirin and clopidogrel are the most important cornerstone agents in this therapy. Aspirin sometimes induces gastric mucosal...
第100回日本消化器病学会総会＞ I　Drug-associated GI Injury：Advances of the pathogenesis and recent clinical topics　2. Recent clinical topics（a）Antiplatelet therapy：Mucosal injuries and drug interaction with PPI